Improving the outcome of patients with castration-resistant prostate cancer through rational drug development

Por Attard, G, Sarker, D, Reid, A, Molife, R, Parker, C, de Bono, J S
Publicado em 2006

Phase II study of docetaxel in patients with relapsed or refractory malignant lymphoma

Por Zekri, J M, Hough, R E, Davies, J M, Molife, R, Hancock, B W, Lorigan, P C
Publicado em 2003